Catalyst Wire Dossier Catalyst Wire Dossier

Activated P53-specific T cells

p53-specific T cells · National Center for Tumor Diseases, Heidelberg
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Activated P53-specific T cells, covering 2018-04-11 to 2018-04-11. Get the full timeline:

Most recent: Clinical Trial Update: Trial of Adoptive T Cell Therapy With Activated P53 Specific T Cells for Treatment of Advanced Colorectal Cancer [Phase 1]

See pricing